The pancreas appears to be a major source of ghrelin during fetal development, but the ontogeny of ghrelin cells in the human pancreas and their developmental relationship with α- and β-cells remain largely unknown. In the present study, we examined the dynamics of ghrelin cell growth, colocalization of ghrelin with major pancreatic hormones and defined the similarities and differences among developmental patterns of ghrelin-, glucagon- and insulin-expressing cells in the human pancreas. To this end, paraffin-embedded pancreatic tissue sections from human embryos and fetuses were assessed by immunohistochemistry. Ghrelin-positive cells were first detected in the pancreas of 11-week-old fetuses. With advancing gestational age, both ghrelin- and glucagon-expressing cells were increasingly observed at the periphery of the developing islets, whereas insulin-containing cells were typically found in the islet core. Double immunohistochemistry showed that ghrelin-expressing cells were clearly separate from insulin-, somatostatin- and pancreatic polypeptide-containing cells. In contrast, cells coexpressing ghrelin and glucagon were sporadically detected during both the early and late fetal periods. Furthermore, morphometric analysis revealed a similar trend in the volume density of ghrelin- and glucagon-positive cells, and a contrasting pattern in β-cell density at specific time points during the development of the human pancreas. This study demonstrates that the developmental pattern of ghrelin cells, although clearly distinct, is quite similar to that of glucagon-expressing cells. The obtained findings indicate a close lineage relationship between these cell populations, a functional relationship between their secretory products and an auto/paracrine mode of ghrelin-glucagon interaction in pancreatic development.

Andralojc, K.M., A. Mercalli, K.W. Nowak, L. Albarello, R. Calcagno, L. Luzi, E. Bonifacio, C. Doglioni, L. Piemonti (2009) Ghrelin-producing epsilon cells in the developing and adult human pancreas. Diabetologia 52: 486–493.
Broglio, F., E. Arvat, A. Benso, C. Gottero, G. Muccioli, M. Papotti, A.J. van der Lely, R. Deghenghi, E. Ghigo (2001) Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. J Clin Endocrinol Metab 86: 5083–5086.
Chanoine, J.P., A.C. Wong (2004) Ghrelin gene expression is markedly higher in fetal pancreas compared with fetal stomach: effect of maternal fasting. Endocrinology 145: 3813–3820.
Chuang, J.C., I. Sakata, D. Kohno, M. Perello, S. Osborne-Lawrence, J.J. Repa, J.M. Zigman (2011) Ghrelin directly stimulates glucagon secretion from pancreatic alpha-cells. Mol Endocrinol 25: 1600–1611.
Clark, A., A.M. Grant (1983) Quantitative morphology of endocrine cells in human fetal pancreas. Diabetologia 25: 31–35.
Cui, C., H. Ohnuma, M. Daimon, S. Susa, H. Yamaguchi, W. Kameda, Y. Jimbu, T. Oizumi, T. Kato (2008) Ghrelin infused into the portal vein inhibits glucose-stimulated insulin secretion in Wistar rats. Peptides 29: 1241–1246.
Date, Y., M. Nakazato, S. Hashiguchi, K. Dezaki, M.S. Mondal, H. Hosoda, M. Kojima, K. Kangawa, T. Arima, H. Matsuo, S. Yada, S. Matsukura (2002) Ghrelin is present in pancreatic alpha-cells of humans and rats and stimulates insulin secretion. Diabetes 5: 124–129.
Desgraz, R., P.L. Herrera (2009) Pancreatic neurogenin 3-expressing cells are unipotent islet precursors. Development 136: 3567–3574.
Dezaki, K., H. Hosoda, M. Kakei, S. Hashiguchi, M. Watanabe, K. Kangawa, T. Yada (2004) Endogenous ghrelin in pancreatic islets restricts insulin release by attenuating Ca2+ signaling in β-cells: implication in the glycemic control in rodents. Diabetes 53: 3142–3151.
Dunne, M.J., K.E. Cosgrove, R.M. Shepherd, A. Aynsley-Green, K.J. Lindley (2004) Hyperinsulinism in infancy: from basic science to clinical disease. Physiol Rev 84: 239–275.
Fowden, A.L., D.S. Gardner, J.C. Ousey, D.A. Giussani, A.J. Forhead (2005) Maturation of pancreatic beta-cell function in the fetal horse during late gestation. J Endocrinol 186: 467–473.
Ghelardoni, S., V. Carnicelli, S. Frascarelli, S. Ronca-Testoni, R. Zucchi (2006) Ghrelin tissue distribution: comparison between gene and protein expression. J Endocrinol Invest 29: 115–121.
Granata, R., A. Baragli, F. Settanni, F. Scarlatti, E. Ghigo (2010) Unraveling the role of the ghrelin gene peptides in the endocrine pancreas. J Mol Endocrinol 45: 107–118.
Heller, R.S., M. Jenny, P. Collombat, A. Mansouri, C. Tomasetto, O.D. Madsen, G. Mellitzer, G. Gradwohl, P. Serup (2005) Genetic determinants of pancreatic epsilon-cell development. Dev Biol 286: 217–224.
Heppner, K.M., J. Tong, H. Kirchner, R. Nass, M.H. Tschöp (2011) The ghrelin O-acyltransferase-ghrelin system: a novel regulator of glucose metabolism. Curr Opin Endocrinol Diabetes Obes 18: 50–55.
Hill, J.T., T.L. Mastracci, C. Vinton, M.L. Doyle, K.R. Anderson, Z.L. Loomis, J.M. Schrunk, A.D. Minic, K.R. Prabakar, A. Pugliese, Y. Sun, R.G. Smith, L. Sussel (2009) Ghrelin is dispensable for embryonic pancreatic islet development and differentiation. Regul Pept 157: 51–56.
Jeon, J., M. Correa-Medina, C. Ricordi, H. Edlund, J.A. Diez (2009) Endocrine cell clustering during human pancreas development. J Histochem Cytochem 57: 811–824.
Jørgensen, M.C., J. Ahnfelt-Rønne, J. Hald, O.D. Madsen, P. Serup, J. Hecksher-Sørensen (2007) An illustrated review of early pancreas development in the mouse. Endocr Rev 28: 685–705.
Kageyama, H., H. Funahashi, M. Hirayama, F. Takenoya, T. Kita, S. Kato, J. Sakurai, E.Y. Lee, S. Inoue, Y. Date, M. Nakazato, K. Kangawa, S. Shioda (2005) Morphological analysis of ghrelin and its receptor distribution in the rat pancreas. Regul Pept 126: 67–71.
Kojima, M., H. Hosoda, Y. Date, M. Nakazato, H. Matsuo, K. Kangawa (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402: 656–660.
Korbonits, M., A.P. Goldstone, M. Gueorguiev, A.B. Grossman (2004) Ghrelin – a hormone with multiple functions. Front Neuroendocrinol 25: 27–68.
Lack, E.E. (2003) Embryology, anatomy, and function of the of the endocrine and exocrine pancreas; in Lack, E.E. (ed): Pathology of the Pancreas, Gallbladder, Extrahepatic Biliary Tract, and Ampullary Region. New York, Oxford University Press, pp 1–44.
Lager, I. (1991) The insulin-antagonistic effect of the counterregulatory hormones. J Intern Med 735: 41–47.
Meier, J.J., C.U. Köhler, B. Alkhatib, C. Sergi, T. Junker, H.H. Klein, W.E. Schmidt, H. Fritsch (2010) Beta-cell development and turnover during prenatal life in humans. Eur J Endocrinol 162: 559–568.
O’Rahilly, R., F. Müller (1987) Developmental Stages in Human Embryos, Including a Revision of Streeter’s ‘Horizons’ and a Survey of Carnegie Collection. Washington, Carnegie Institution.
O’Rahilly, R., F. Müller (2010) Developmental stages in human embryos: revised and new measurements. Cells Tissues Organs 192: 73–84.
Popović, V. (2006) Ghrelin. Curr Opin Endocrinol Diabetes 13: 70–75.
Portela-Gomes, G.M., H. Johansson, L. Olding, L. Grimelius (1999) Co-localization of neuroendocrine hormones in the human fetal pancreas. Eur J Endocrinol 141: 526–533.
Prado, C.L., A.E. Pugh-Bernard, L. Elghazi, B. Sosa-Pineda, L. Sussel (2004) Ghrelin cells replace insulin-producing β cells in two mouse models of pancreas development. Proc Natl Acad Sci USA 101: 2924–2929.
Remacle, C., O. Dumortier, V. Bol, K. Goosse, P. Romanus, N. Theys, T. Bouckenooghe, B. Reusens (2007) Intrauterine programming of the endocrine pancreas. Diabetes Obes Metab suppl 2: 196–209.
Silver, M., A.L. Fowden, R.S. Comline, S.R. Bloom (1986) Pancreatic alpha cell function in the fetal and newborn pig. J Endocrinol 108: 137–142.
Taborsky, G.J. Jr (2010) The physiology of glucagon. J Diabetes Sci Technol 4: 1338–1344.
Tesauro, M., F. Schinzari, M. Caramanti, R. Lauro, C. Cardillo (2010) Cardiovascular and metabolic effects of ghrelin. Curr Diabetes Rev 6: 228–235.
Ueberberg, B., N. Unger, W. Saeger, K. Mann, S. Petersenn (2009) Expression of ghrelin and its receptor in human tissues. Horm Metab Res 41: 814–821.
Volante, M., E. Allìa, P. Gugliotta, A. Funaro, F. Broglio, R. Deghenghi, G. Muccioli, E. Ghigo, M. Papotti (2002) Expression of ghrelin and of the GH secretagogue receptor by pancreatic islet cells and related endocrine tumors. J Clin Endocrinol Metab 87: 1300–1308.
Walia, P., A. Asadi, T.J. Kieffer, J.D. Johnson, J.P. Chanoine (2009) Ontogeny of ghrelin, obestatin, preproghrelin, and prohormone convertases in rat pancreas and stomach. Pediatr Res 65: 39–44.
Weibel, E.R. (1979) Stereological Methods, vol. 1: Practical Methods for Biological Morphometry, ed 1. London, Academic Press.
Wierup, N., F. Sundler (2005) Ultrastructure of islet ghrelin cells in the human fetus. Cell Tissue Res 319: 423–428.
Wierup, N., H. Svensson, H. Mulder, F. Sundler (2002) The ghrelin cell: a novel developmentally regulated islet cell in the human pancreas. Regul Pept 107: 63–69.
Wierup, N., S. Yang, R.J. McEvilly, H. Mulder, F. Sundler (2004) Ghrelin is expressed in a novel endocrine cell type in developing rat islets and inhibits insulin secretion from INS-1 (832/13) cells. J Histochem Cytochem 52: 301–310.
Yada, T., K. Dezaki, H. Sone, M. Koizumi, B. Damdindorj, M. Nakata, M. Kakei (2008) Ghrelin regulates insulin release and glycemia: physiological role and therapeutic potential. Curr Diabetes Rev 4: 18–23.
Yakabi, K., J. Kawashima, S. Kato (2008) Ghrelin and gastric acid secretion. World J Gastroenterol 14: 6334–6338.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.